Description
GLP-2 – TIRZ 40 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
This listing is not an MHRA-licensed medicine.
Research-grade synthetic peptide supplied as a 40 mg sealed vial for lawful laboratory research in the UK. Catalogue name on the label: GLP-2 – TIRZ. Not a food, supplement or medical device. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
Licensed tirzepatide products (Mounjaro / Zepbound) are separate prescription medicines. This vial is not those products.
Identification
| Catalogue name | GLP-2 – TIRZ |
| Also listed as | Tirz; GLP-2 (catalogue slang only) |
| Research identity | Tirzepatide |
| Supplier | Opti-Gen Peptides |
| Contents | 40 mg per vial |
| CAS | 2023788-19-2 |
| Class | Synthetic dual GIP / GLP-1 receptor analogue |
| Intended use | Laboratory / in-vitro research only |
GLP-2 is not an INN for this peptide. Not teduglutide. Not semaglutide. Not retatrutide.
Quality / storage
Only the lot COA applies. Store as a laboratory peptide under institutional SOP. No reconstitution, pen-loading or injection instructions on this page.
Published research context (not product claims)
Tirzepatide is described in literature as a dual GIP / GLP-1 receptor analogue. Receptor papers characterise that pharmacology in experimental systems.
Clinical-development programmes produced authorised medicines. SURPASS / SURMOUNT-type papers concern licensed presentations. They must not be rewritten as weight-loss or diabetes claims for this vial.
Shop slang “GLP-2” here is a catalogue label only. There is no authorisation to market this vial as a UK medicine.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.